ESPR
Esperion Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.18
+0.00%Jun 1, 2026, 00:00 UTC
Esperion Therapeutics, Inc. elected J. Martin Carroll and Sheldon L. Koenig as Class I Directors, effective May 28, 2026.